0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

TERRAMYCIN IN TREATMENT OF HUMAN BRUCELLOSIS

VERNON KNIGHT, M.D.; FRANCISCO RUIZ SANCHEZ, M.D.; AMADO RUIZ SANCHEZ, M.D.
AMA Arch Intern Med. 1951;87(6):835-843. doi:10.1001/archinte.1951.03810060064007.
Text Size: A A A
Published online

CONVINCING evidence is now available to indicate that aureomycin and chloramphenicol are effective in suppressing the acute manifestations of brucellosis.1 Substantial numbers of patients have had prompt clinical remissions of the acute illness following treatment with both these agents. Despite improvement in treatment of the acute infection, however, there remains a serious therapeutic problem in the occurrence of an appreciable number of relapses. In the several series reported, including those described by us, the rate of relapse has ranged from less than one fourth to approximately one half of the total patients treated. Among the many factors which may influence the relapse rate is one common to virtually all the aforementioned studies, namely, a limitation of the total length of antimicrobial therapy to a period of about two weeks or less. In these various studies the regimens of therapy were principally determined by the amount of drug available, and

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();